Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Labopharm says FDA has issues with tramadol application
In its letter to the company, the FDA indicated that Labopharm’s once-daily formulation of tramadol is approvable subject to clearing up some deficiencies in the application, which Labopharm
In its letter to the company, the FDA indicated that Labopharm’s once-daily formulation of tramadol is approvable subject to clearing up some deficiencies in the application, which Labopharm
Under the terms of the agreement, TAP will be responsible for promoting Famvir to the Obstetrician and Gynecology medical community. Famvir is the first and only oral antiviral
These trials were conducted to investigate the safety, tolerability and pharmacokinetics of intravenous and intramuscular injections of peramivir in healthy volunteers. The company said that in additional studies
The Hart-Scott-Rodino waiting period for the Barr’s acquisition of Shire’s Adderall expired without further action from the US Federal Trade Commission. As a result, the product acquisition agreement
The agreement will attempt to determine whether GelVac is adaptable for delivering human papillomavirus virus (HPV)vaccines in a powder dosage form for mucosal immunization. In June the FDA
Zanamivir is the active ingredient in Relenza which was developed by GSK under license from Biota Holdings. “This agreement with Simcere is intended to expand available supplies of
The deal is subject to the approval of the product by Health Canada. Atripla is the first once-daily single tablet regimen for HIV intended as a stand-alone therapy
The study was designed to evaluate patient adherence to long-term treatments for multiple sclerosis in a real-world setting. Non-adherence was defined as missing at least one injection or
NovaDel said that a pharmacokinetic study of its improved oral spray formulation of sumatriptan demonstrated positive results. Sumatriptan is the active ingredient in GlaxoSmithKline’s leading migraine remedy, Imitrex.
Formulated with the company’s proprietary vitamin E-based Tocosol technology, Tocosol Camptothecin is a new chemical entity that is a conjugate of SN-38. SN-38 is the active ingredient in